LIVE PRESS CONFERENCE: Union World Conference on Lung Health : M72 Vaccine study primary results presented

The primary results from the M72/AS01E candidate vaccine study were announced during a press conference held at the Union World Conference on Lung Health.

Professor Mark Hatherill, SATVI Director presented the results from the clinical research.

Chair: Paula Fujiwara, Scientific Director, International Union Against Tuberculosis and Lung Disease (The Union)

Speakers:

1. Thomas Ottenhoff, Co-Chair, TB Science 2018, Time to talk about a TB vaccine
2. Marie-Ange Demoitie, Glaxo -Smith Kline, M72 Prevention of disease trial- preliminary results
3. Mark Hatherill, SAVTI, Impact of Recent vaccine results - the way forward
4. Ann Ginsberg, IAVI, Next steps towards a TB vaccine
5. Lucica Ditiu, Executive Director, STOP TB Partnership, A community perspective

Remote video URL